SynthesisBMC cardiovascular disorders2026
Exercise modalities and dose for improving arterial stiffness in risk-enriched adults: a systematic review and dose-response network meta-analysis.
Synthesis in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exercise in Patients with Subclinical Atherosclerosis: Mechanisms, Clinical Evidence, and Practical Recommendations.Current atherosclerosis reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundExercise is recommended for cardiovascular prevention, but the comparative effects of different exercise modalities and weekly doses on carotid-femoral pulse wave velocity (cfPWV) in heterogeneous risk-enriched adults with cardiovascular risk-related conditions or characteristics remain uncertain. This systematic review and dose-response network meta-analysis aimed to compare exercise modalities for improving cfPWV and to explore model-derived dose-response patterns and approximate favorable dose regions.
methodsPubMed, Cochrane Library, Web of Science, Embase, SPORTDiscus, and CINAHL were searched from inception to 22 February 2026 for English-language parallel-group randomized controlled trials reporting cfPWV in heterogeneous risk-enriched adults with cardiovascular risk-related conditions or characteristics. Pairwise meta-analysis, frequentist network meta-analysis, and Bayesian dose-response network meta-analysis were performed.
resultsThirty-seven studies involving 2,110 participants were included. In direct pairwise analysis, exercise was associated with a reduction in cfPWV compared with control (WMD = -0.65, 95% CI -1.13 to -0.18), but heterogeneity was considerable (I² = 94.4%). Aerobic training and whole-body vibration training showed significant reductions versus control in modality-specific direct comparisons, whereas resistance training, combined training, interval training, and isometric handgrip training did not reach statistical significance. In the network meta-analysis, aerobic training (WMD = -0.65, 95% CI -1.08 to -0.22) and interval training (WMD = -1.07, 95% CI -1.66 to -0.49) were associated with lower cfPWV than control. The dose-response model suggested a nonlinear association, with the lower model-derived crossing region around 200-300 MET·min/week and the lowest fitted estimate around 700-800 MET·min/week at the overall exercise level. However, these values are approximate model-derived ranges, not exact clinical thresholds, and should be interpreted cautiously because of clinical heterogeneity, sparse evidence in some dose regions and exercise nodes, and uncertainty around threshold estimates.
conclusionsExercise may reduce cfPWV in heterogeneous risk-enriched adults with cardiovascular risk-related conditions or characteristics, particularly through aerobic and interval-based training in the network synthesis. Direct pairwise evidence supported exercise overall, aerobic training, and whole-body vibration training, but the certainty of evidence was generally low or very low and heterogeneity was considerable. The dose-response findings suggest a potential moderate-dose region with lower model-predicted cfPWV estimates at the overall exercise level, but these estimates should be considered model-derived and hypothesis-generating rather than definitive clinical prescription thresholds. These findings should be interpreted as average effects across diverse populations and exercise prescriptions rather than as uniform expected effects.
trial registrationPROSPERO CRD420261372601.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.